Lund University Hospital

The trials here

What the 28 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Atrial fibrillation2 trials
• Chronic lymphocytic leukaemia2 trials
• Coronary artery disease2 trials
• Multiple myeloma2 trials
• Prostate cancer2 trials
• Acute myeloid leukaemia1 trial
• Aortic stenosis1 trial
• Asthma1 trial
• Chronic myeloid leukaemia1 trial
• Colorectal cancer1 trial
• Diabetic eye disease1 trial
• and 11 more

Phase

• Phase 25 trials
• Phase 35 trials
• Phase 12 trials
• Phase 42 trials
• Phase 1/21 trial

Status

• Active, not recruiting11 trials
• Recruiting11 trials
• Not yet recruiting4 trials
• Completed2 trials

Lead sponsor

• Lund University Hospital4 trials
• Karolinska Institutet2 trials
• Karolinska University Hospital2 trials
• Region Skane2 trials
• BeOne Medicines1 trial
• and 17 more

Running trials

• Recruiting

  Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice

  NCT07651891· Phase 4· Karolinska Institutet· Source

  Contact: Franziska Nordström, MD

• Not yet recruiting

  Rituximab as therapy for autoantibody mediated fibromyalgia (RAFT) - proof of concept

  2025-523465-21-00· Phase 3· Region Stockholm – SLSO· Source

• Active, not recruiting

  COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

  NCT07455097· Heinrich-Heine University, Duesseldorf· Source

• Recruiting

  A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

  NCT06943872· Phase 3· BeOne Medicines· Source

• Recruiting

  Prolonged Chest Tube Treatment to Reduce Rates of Atrial Fibrillation Following Cardiac Surgery

  NCT06800781· Region Skane· Source

  Contact: Igor Zindovic, MD, Phd

• Recruiting

  Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)

  NCT06401616· Phase 4· Odense University Hospital· Source

• Recruiting

  a Multicentre Phase III Study of Risk-based Treatment Intensification With Hyperfractionated Radiotherapy in Head and Neck Cancer Patients

  NCT06248996· Phase 3· Lund University Hospital· Source

  Contact: Maria Gebre-Medhin, MD

• Recruiting

  Improving CRT Outcome With Non-Invasive Cardiac Mapping

  NCT05564793· EP Solutions SA· Source

  Contact: Rasmus Borgquist, Dr

• Active, not recruiting

  BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

  NCT06205706· Phase 1/2· BioInvent International AB· Source

• Recruiting

  Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

  NCT05879757· Takeda· Source

  Contact: Goran Jonsson (principal investigator)

• Active, not recruiting

  A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

  NCT05476926· Hoffmann-La Roche· Source

• Recruiting

  This is a first in human study, in patients with severe bleeding disorder (hemophilia A), who has developed inhibitory antibodies against coagulation factor VIII.The aim is to study the safety and efficacy of dendritic cells, originating from the patient itself. The dendritic cells has been loaded with coagulation factor VIII for an improved immunological tolerance. (TOLER8)

  2022-502030-12-01· Phase 1· Cell4Cure AB· Source

• Recruiting

  Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling

  NCT05431257· Phase 2· Copenhagen University Hospital, Rigshospitalet· Source

• Active, not recruiting

  Is there a survival benefit of administering thoracic radiotherapy concurrently with immunnotherapy and chemotherapy for patients with extensive stage small-cell lung cancer?

  NCT05223647· Phase 3· Norwegian University Of Science And Technolology· Source

• Active, not recruiting

  Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma

  NCT05214183· Phase 2· Nordic Lymphoma Group· Source

• Recruiting

  Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.

  NCT04858880· Lund University Hospital· Source

  Contact: Adalsteinn Gunnlaugsson, MD, PhD

• Recruiting

  Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma

  NCT04462042· Umeå University· Source

  Contact: Martin Nilsson, MD

• Active, not recruiting

  First in Men Study: BIOMAG-I

  NCT04157153· Biotronik AG· Source

• Active, not recruiting

  A randomized double blind, multicenter trial to assess time-interval between cytoreductive surgery and adjuvant chemotherapy after administration of local anesthetic intraperitoneally/perioperatively in advanced epithelial ovarian cancer - IPLA-OVCA

  2023-507732-20-00· Phase 3· Karolinska University Hospital· Source

• Completed

  Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis

  NCT03831776· Phase 2· St. Olavs Hospital· Source

• Recruiting

  Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)

  NCT03758976· Lund University Hospital· Source

  Contact: Karolina Holm, PhD

• Active, not recruiting

  Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

  NCT03540420· Phase 2· Norwegian University of Science and Technology· Source

• Recruiting

  The Swedish Essential Tremor (SWEET) Trial

  NCT03832712· Karolinska Institutet· Source

  Contact: Hjalmar Bjartmarz, MD

• Active, not recruiting

  Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

  NCT03376672· Phase 2· Raija Silvennoinen· Source

• Active, not recruiting

  Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation

  NCT03058627· Thomas Engstrom· Source

• Recruiting

  BioMEL- Diagnostic and Prognostic Factors in Melanoma.

  NCT05446155· Region Skane· Source

  Contact: Kari Nielsen, Ass. Prof.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation2 recruiting
• Acute myeloid leukaemia1 recruiting
• Asthma1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Essential tremor1 recruiting
• Fibromyalgia1 recruiting
• Haemophilia1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  Intermittent ibrutinib in chronic lymphocytic leukemia

  2023-508638-32-00· Phase 1· Karolinska University Hospital· Source

• Completed

  Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial.

  NCT02246725· Lund University Hospital· Source